Featured Bioinformatics Experts

I am a Bioinformatician with extensive experience of analyzing Genomics and Transcriptomics data from Next Generation Sequencing Platforms. I enjoy designing, implementing and automating computational pipelines for Biological Data Analysis using multiple programming languages. I also possess over three years of experience working in wet lab with several Molecular Biology tools. I have worked as teaching assistant for both undergrads and grad students.I enjoy solving problems independently as well as by being part of a collaborative inter-disciplinary team.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Vinothkumar Kolluru is a Senior Data Scientist at Fractal Analytics with 9+ years of experience in NLP, Machine Learning, and Deep Learning. He builds AI-driven solutions that improve customer experience and decision-making, with a focus on customer segmentation, friction detection, and digital journey optimization for large-scale web platforms. He has delivered end-to-end models across tech, healthcare, and marketing—ranging from NLP-based document summarization and topic categorization to predictive analytics—using transformer architectures (e.g., BERT), sequence models, and classical ML. Vinoth has also led analytics initiatives such as call categorization for healthcare contact centers and relevance modeling to improve campaign targeting and performance. A passionate researcher and contributor to the AI community, Vinoth has 50+ publications and 246 citations (h-index 9). He is recognized with the Dr. Abdul Kalam Young Achiever National Award and holds an MS in Data Science from Stevens Institute of Technology, along with a Gold Medal in Engineering from Anna University. His core toolkit includes Python, SQL, AWS, and Azure, and he enjoys translating complex data into practical, measurable business impact.

Ian Bann is an AI-driven SEO strategist focused on diagnosing how authority and visibility break inside AI-generated search results. His work examines AI search visibility, attribution behaviour, and why strong websites lose visibility despite strong traditional SEO signals. He studies how AI systems interpret, summarise, and reuse website content, and why certain sources are selected while others are ignored. Ian focuses on AI search visibility, entity clarity, and the structural signals that influence attribution and trust in generative search environments. He shares practical observations, analysis and what ai tools to use to tract how AI systems surface information and what changes improve visibility inside AI-generated answers. Edit

Dhyey is an AI & computational math researcher at Amherst College. His work sits between statistical learning and mathematical rigor, developing methods and software for robust modeling, efficient computation, and machine-assisted reasoning. He's especially interested in bridging foundations (proofs, geometry, probability) with practical ML systems. Previously he has published novel open-source Python packages amassing 40k+ downloads, and published papers with professors and executives of Fortune 500 companies. He's an active guest author and contributing writer to major industry media publications such as VentureBeat, LeadDev, DZone, etc.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

R.G.C.C. International GmbH is a leading company in analysis of circulating tumor cells as well as Cancer Stem Cells.Through our high quality analysis at R.G.C.C. International GmbH we are able to offer a full ranges of services to the R & D, clinical, and pharmaceutical industry.By using the most advanced and innovative technologies of molecular and cellular

With over 15 years of hands-on experience in affiliate marketing, e-commerce, and digital growth strategy, I’ve helped brands scale profitable online partnerships and build high-performing affiliate ecosystems. As the founder of BestAIFor.com - a fast-growing AI tools directory, benchmark platform, and independent review hub - I now combine my performance marketing background with deep expertise in the AI landscape. I personally evaluate and benchmark hundreds of AI tools every month, tracking real-world metrics like speed, accuracy, pricing shifts, ROI, and usability across productivity, content, marketing, and creative workflows. My work focuses on cutting through the hype to deliver actionable, data-backed insights that help solopreneurs, marketers, and businesses choose the right AI stack for 2026 and beyond. Whether I'm setting up affiliate programs for AI tool makers, optimizing campaign performance with AI-powered automation, or identifying emerging trends through original benchmarks, I’m driven by one goal: turning complex technology into practical growth advantages. I’m passionate about sharing transparent, no-BS analysis and helping the industry move faster with better information. You’ll often find me publishing fresh benchmarks, “State of AI Tools” micro-reports, and strategic guides on BestAIFor.com.

I am an SEO expert with over 2 years of hands-on experience in on-page, off-page, and AI-driven SEO strategies. I have a strong grip on off-page SEO, especially Cloud stacking and Google Cloud stacking backlink creation to improve domain authority and search visibility. My expertise includes AI-based keyword research, technical SEO, site speed optimization, content optimization, and high-quality backlink building. I also have solid experience in blogging, Pinterest blogging, and optimizing tool-based websites for scalable organic growth. I focus on data-driven strategies to deliver sustainable, long-term results across multiple niches.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

Muhaiminul Islam Sajib is an experienced SEO strategist with a proven track record of driving measurable growth for businesses worldwide. He has worked with 200+ businesses and optimized 300+ websites across a wide range of industries. As a Top Rated Plus SEO Strategist on Upwork with a 100% Job Success rate, he is recognized for reliability, performance, and long-term client satisfaction. Sajib developed his SEO expertise through years of practical, real-world implementation and holds recognized SEO certifications from HubSpot and Semrush. His work is highly international in scope, having successfully supported businesses based in the USA, UK, Canada, and Australia. Local SEO is his core specialty, and around 80% of his clients are local businesses that rely on sustainable visibility and long-term lead generation. He has successfully managed and optimized more than 100 Google Business Profiles (GBP) till December 2025. He is also the inventor of the V-E-E-A-T framework, emphasizing Value, Expertise, Experience, Authority, and Trustworthiness in the digital marketing space.

Ilya J. Finkelstein, PhD is a Professor of Molecular Biosciences at The University of Texas at Austin specializing in gene editing, biophysics, and biotechnology. He has published 100+ peer-reviewed papers, holds multiple patents, and has served as an expert witness and technical consultant. His work appears frequently in scientific and popular press.

I am the Co-Founder and Chief Product Officer at Mantalys, an AI start-up based in Toulouse, France dedicated to bringing lightweight, high-performance AI solutions to biomedical image analysis. With a PhD in neuro-immunology and five years of post-doctoral research experience in tumor immunology, I bring deep biomedical expertise to the computer vision team - bridging science and technology to unlock real world insights and extract actionable intelligence from biomedical images.

As the CMO and Founding Member of AiNews.com, I’m passionate about making AI news accessible and understandable to audiences worldwide. My journey in AI journalism and digital marketing has been driven by a commitment to responsible, transparent reporting and a vision of democratizing AI insights. At AiNews.com, we bring the latest in AI developments to a global readership, blending timely, in-depth reporting with cutting-edge storytelling, including AI avatars that bring complex stories to life. I helped found AiNews.com to fill a gap in aggregating trustworthy AI news in one place, helping leaders in AI and tech stay informed on impactful trends while minimizing their time in searching for news. Our team’s dedication to transparency and ethical reporting has established AiNews.com as a respected source among AI enthusiasts, tech leaders, and business decision-makers. Journalists interested in AI's evolving impact on business, society, and emerging tech will find AiNews.com’s perspective invaluable. I'm excited to connect, collaborate, and share insights that contribute to understanding and shaping AI's future.

Mohit Sharma is the Founder of AISEOToolsHub, a leading platform dedicated to exploring the latest developments in artificial intelligence. Through AISEOToolsHub, he shares updates on trending AI tools, features, and daily insights, along with practical guides to help users stay ahead in the evolving AI landscape. In addition to his work in AI,Mohit is also the Founder of Study Pariksha, an educational platform designed to support students with accessible and effective learning resources. With over 5 years of experience in SEO and digital marketing, Mohit began his career as an SEO Executive, where he honed his expertise in search engine optimization, keyword ranking, and online growth strategies. Over the years, he has built and managed multiple successful websites and tools, and has worked as a freelancer providing SEO services to clients across the globe. Driven by innovation and a passion for technology, Mohit continues to bridge the gap between AI advancements and digital growth, empowering both individuals and businesses through his platforms.

Dr Berkan Sesen is an AI researcher and quantitative finance practitioner with 15+ years of experience across investment banking and healthcare AI. At JP Morgan Asset Management, he led the development of ML-powered thematic investment funds managing over $2B AUM. At UBS, he headed the algorithmic execution and AI team. He previously developed AI/ML solutions for algorithmic trading at Citigroup. He holds a DPhil in Artificial Intelligence from the University of Oxford and has authored 15 publications and patents, including peer-reviewed papers in the Journal of the Royal Society Interface, PLOS ONE, and AMIA, two US patent applications, and book chapters in Wiley Finance. His recent research includes work on generative models (arXiv 2024) and RAG validation for clinical cases (medRxiv 2025). He is co-founder of Tinie.ai (digital health, UKABIF Innovation Award 2024) and the A.I.M. Research Lab. He advises AI startups through Techstars and AI Forge.

James Bean is a pioneering cannabis industry expert and Founding CEO of Seeds Here Now, the longest continuously operating seed bank in the United States with 15 years of proven leadership. Since 2010, Bean has built an industry-leading catalog featuring 3,500+ strains from 80+ world-class breeders, establishing Seeds Here Now as the premier destination for authentic cannabis genetics. With a Plant Science degree from Oaksterdam University and 15 years specializing in cannabis genetics, Bean brings unparalleled expertise in breeder verification, genetic authenticity, and cultivation science. His knowledge spans feminized, regular, and autoflower seed production, pheno-hunting, breeding practices, and strain lineage documentation. Bean's industry authority is demonstrated through extensive media presence on major cannabis podcasts including The Adam Dunn Show (as "James Bean Man on the Scene"), The Dude Grows Show, The Pot Cast, and Grow Bud Yourself Podcast. He has personally vended at hundreds of cannabis trade shows including High Times Cannabis Cups and Canna Con events, and serves as a cannabis competition judge. As a heavy cannabis consumer with decades of personal experience, Bean possesses exceptional first-hand knowledge of strain effects and quality assessment. His business has served thousands of satisfied customers with germination guarantees and transparent practices, earning recognition including the 2023 Leafly Seed Bank Hall of Fame honor and Forbes media coverage. Bean actively supports cannabis community causes, mentors emerging businesses, and contributes educational content through articles and podcast appearances. His direct relationships with renowned breeders like TH Seeds, Exotic Genetics, La Plata Labs, Snow High Seeds, and Dominion Seed Company underscore his trusted position as the "#1 U.S. Broker of High Quality Cannabis Genetics." Based in Tulsa, Oklahoma, Bean continues to shape cannabis breeding trends, preserve rare genetics, and advance industry professionalism while maintaining Seeds Here Now's position as America's most trusted source for authentic cannabis seeds.